Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)
China · Delayed Price · Currency is CNY 28.70
-0.22 (-0.76%)
At close: Sep 4, 2026
SHA:688273 Market Cap
SHA:688273 has a market cap or net worth of 2.83 billion as of September 4, 2026. Its market cap has decreased by -27.66% in one year.
Market Cap
2.83B
Enterprise Value
2.16B
Revenue
383.30M
Ranking
n/a
PE Ratio
37.49
Stock Price
28.70
ChartMarket Cap Chart
Since August 11, 2022, SHA:688273's market cap has decreased from 4.41B to 2.83B, a decrease of -35.82%. That is a compound annual growth rate of -10.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.81B | -32.50% |
| Dec 31, 2025 | 4.16B | 81.85% |
| Dec 31, 2024 | 2.29B | -31.77% |
| Dec 29, 2023 | 3.35B | 2.81% |
| Dec 30, 2022 | 3.26B | -26.03% |
| Aug 11, 2022 | 4.41B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Succeeder Technology | 3.41B |
| Ningbo David Medical Device | 3.38B |
| Wuhan Easy Diagnosis Biomedicine | 3.38B |
| Beijing Leadman Biochemistry | 3.27B |
| Chison Medical Technologies | 3.17B |
| Tellgen | 3.07B |
| Shanghai ZJ Bio-Tech | 3.03B |
| Shanghai Kehua Bio-Engineering Co.,Ltd | 2.93B |